期刊文献+

结核杆菌活动期高表达基因Rv1776c的克隆及其在耻垢分枝杆菌中的表达

Cloning of high expression gene Rv1776c in active phase of Mycobacterium tuberculosis and its expression in Mycobacterium smegmatis
原文传递
导出
摘要 目的构建表达结核分枝杆菌Rv1776c基因的重组耻垢分支杆菌,并鉴定该基因在重组耻垢分支杆菌中的活性。方法采用PCR技术克隆结核分枝杆菌Rv1776c基因,构建大肠埃希菌-分支杆菌穿梭表达质粒pMV-Rv1776c,通过酶切和测序鉴定其正确性,用电穿孔法将重组质粒转染到耻垢分支杆菌mc^2155中。以SDS-PAGE及Western blot检测证实Rv1776c蛋白在重组耻垢分支杆菌内的表达。结果重组耻垢分支杆菌构建成功,生长曲线说明重组质粒不会影响耻垢分支杆菌的体外生长;SDSPAGE及Western blot检测证实Rv1776c在耻垢分枝杆菌内表达出相对分子量约56kD的Rv1776c蛋白。结论成功构建了Rv1776c基因的穿梭质粒pMV-Rv1776c,且该质粒在耻垢分枝杆菌内具有生物活性,为进一步研究其表达产物的功能提供基础。 Objective To construct a recombinant Mycobacterium tuberculosis Rv1776c gene,and identify its activity in recombinant Mycobacterium smegmatis.Methods PCR method was used to clone Mycobacterium tuberculosis Rv1776c gene.Escherichia coli-mycobacteria shuttle expression plasmid pMV-Rv1776c was constructed,and confirmed by enzyme digestion and sequencing.The recombinant plasmid was transfected into Mycobacterium smegmatis mc^2 155 with electroporation method.The expression of Rv1776c protein in recombinant Mycobacterium smegmatis was confirmed by using SDS-PAGE and Western blot.Results The recombinant Mycobacterium smegmatis was constructed successfully.The growth curve showed that the recombinant plasmid did not affect the growth of Mycobacterium smegmatis in vitro.SDS-PAGE and Western blot confirmed that the Rv1776c expressed in the Mycobacterium smegmatis had a relative molecular weight of about 42 kD.Conclusion The shuttle plasmid pMV-Rv1776c of Rv1776c gene was successfully constructed,and its biological activity was also expressed in Mycobacterium smegmatis,which provides the basis for further research on its function.
出处 《中国微生态学杂志》 CAS CSCD 2018年第1期27-30,共4页 Chinese Journal of Microecology
基金 重庆市医疗特色专科项目 重庆市区域重点学科建设项目(zdxk201701) 重庆市江津区科技计划项目(Y2017001)
关键词 Rv1776c基因 pMV-Rv1776c 重组耻垢分枝杆菌 Rv1776c gene pMV-Rv1776c Recombinant Mycobacterium smegmatis
  • 相关文献

参考文献2

二级参考文献11

  • 1汪万英,何杰,张世馥,姚敏,唐素兰.金葡菌及其L型感染荷瘤小鼠的实验研究[J].中国微生态学杂志,1996,8(5):38-39. 被引量:21
  • 2MADDAAN S,ABCL P D, CHAUDHARY K S, et al. Cytoplasmie induction and over expression of Cyelooxygenase- 2 in human prostate cancer: imp licafions for prevention and treatment[ J ]. BJU Int,2000, 86(6) :736-741.
  • 3POLD M,ZHU X L, SHARMA S,et al. Cyelooxygenase-2 dependent expression of angiogenie CXC ehemokines ENA-78/CXC ligand [ CXCL]5 and intefleukin- 8/CXCI.g in human non-small cell lung cancer [J]. Cancer Res,2004,64(5) :1853-1860.
  • 4LIND T, SUBBARAMAISH K, SHAH J P, et al. Cyloooxygenase-2 : a novel moleoulartarget for thepreventlon and treatment of head and neck cancer[ J ]. Head Neck ,2002,24 (8) :792-799.
  • 5ITO H, DUXBURY M, BENOIT E. Prostaglandin 1/12 enhances pancreatic cancer invasiveness through an Ets-Independcnt induction of matrix metalloproteinase-2 [ J]. Cancer Res,2004,64(20) :7439-7446.
  • 6VELIIKOVIC L J, DORDEVIC B, RANCIC G, et al. Expresion of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma[ J]. Vojnosanit Pregl,2007,64(5 ) :325-330.
  • 7SANTINELLI A, MAZZUCCHELLI R, BARBISAN F, et al. alpha- Methylacyl coenzyme A racemase, Ki.67, and topoisomerase Ⅱ alpha in cystop rostatectomies with incidental prostate cancer [ J ]. Am J Clin Pathol,2007,128 (4) :657-666.
  • 8LAITINEN S, MARTIKAINEN P M, TOLONEN T, et al. EZH2, Ki-57 and MCM7 are prognostic markers in prostateetomy treated patients [J]. Int J Cancer,2008,122(3 ) :595-602.
  • 9KAUSCH I, LINGNAU A, ENDL E, et al. Antisense treatment against KI-67Mma inhibits proliferation and tumor growth in vitro and in vivo [J]. Int J Cancer,2003,105(5) :710-716.
  • 10李超,周洋,陈力,向小勇.Ki-67与肺癌的临床研究进展[J].重庆医学,2008,37(6):647-649. 被引量:2

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部